How to Buy Apogee Therapeutics Stock
Apogee Therapeutics Inc
Apogee Therapeutics, Inc. , through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications.
Apogee Therapeutics stock last closed at $78.42, down 0.14% from the previous day, and has increased 95.37% in one year. It has overperformed other stocks in the Biotechnology industry by 1.28 percentage points. Apogee Therapeutics stock is currently +199.31% from its 52-week low of $26.20, and -7.78% from its 52-week high of $85.04.
At the moment, there are 69.49M APGE shares outstanding. The market value of APGE is $5.45B. In the last 24 hours, 1.05M APGE shares were traded.
How to Buy Apogee Therapeutics Stock
Not sure how to invest in Apogee Therapeutics stock? Here's how.
- Choose where to buy Apogee Therapeutics stock: You need to pick an online brokerage, but don't worry - we've sifted through dozens of online stock brokerages and apps to help you determine where to buy Apogee Therapeutics stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit funds into your brokerage account: Select your payment method and add your info.
- Research Apogee Therapeutics stock: The Apogee Therapeutics ticker symbol is APGE. Is Apogee Therapeutics stock a good investment? Should you buy shares of APGE? How do APGE's underlying business fundamentals look? Do top analysts think Apogee Therapeutics is a good buy? Why has APGE's stock price moved recently? (Hint: Our stock market analysis website can help you decide if APGE is a good stock to buy).
- Make your APGE buy order: Decide if you will purchase APGE shares at the current market price or use a limit order to purchase APGE stock at a specific price.
- Get key alerts regarding your APGE investment: Create a watchlist to track your new investment in Apogee Therapeutics stock.
Step 1: Choose where to buy Apogee Therapeutics stock
You will need an online brokerage account to access the NASDAQ market and buy APGE stock.
Our preferred brokerage: eToro
We believe that eToro is the best brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to global financial markets: From Tech to Real Estate, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've picked the best brokerage, you'll need to fill out some personal information so you can buy APGE stock today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to start a new trading account.
- Submit your details by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you have created your account on the best beginner stock app, your next step is to transfer the money for your investment:
Check out this video walkthrough if you need help depositing money into your investment account.
Step 4: Research Apogee Therapeutics stock
After you have selected the best place to buy Apogee Therapeutics stock, it's very important to evaluate their stock before you buy, so you actually understand the risk and opportunity.
Apogee Therapeutics Metrics
Fundamentals of APGE
WallStreetZen was designed to help average investors perform more in-depth fundamental analysis quickly.
You can view all of the due diligence checks on APGE's stock page.
Is APGE stock properly valued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge APGE's true value.
Using relative valuations metrics:
- APGE could be overvalued based on its P/B ratio of 6.03x, relative to Biotechnology industry P/B ratio of 4.64x
You can access additional valuation analysis on APGE's stock here.
A look at APGE Cashflows and Balance Sheet
Passed Financial Due Diligence Checks:
- There are more short-term assets than short-term liabilities on the APGE balance sheet.
- APGE has cash burn of 232597000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the APGE balance sheet.
- APGE has a low debt to equity ratio of 0.04.
Failed Financial Due Diligence Checks:
- APGE has $730.19M in cash and short term investments. This is not enough to cover its annual cash burn of $232.60M.
Do Wall Street analysts think it's a good time to buy Apogee Therapeutics stock
Out of 11 Equities analysts who research APGE, the consensus analyst rating on Apogee Therapeutics is a Strong Buy
Please keep in mind that analyst forecasts are not recommendations, nor are they financial advice.
Latest APGE Analyst Upgrades/Downgrades
Brian Abrahams, a top 15% analyst from RBC Capital maintains APGE with a hold rating and lowers their APGE price target from $83.00 to $82.00, on Mar 3, 2026.
David Nierengarten, a top 5% analyst from Wedbush maintains APGE with a buy rating and raises their APGE price target from $90.00 to $95.00, on Mar 3, 2026.
Sudan Loganathan, a top 28% analyst from Stephens & Co. initiates coverage on APGE with a strong buy rating and announces their APGE price target of $95.00, on Dec 17, 2025.
David Hoang, a top 10% analyst from Deutsche Bank initiates coverage on APGE with a strong buy rating and announces their APGE price target of $103.00, on Dec 10, 2025.
Adam Vogel, a top 41% analyst from Craig-Hallum initiates coverage on APGE with a buy rating and announces their APGE price target of $109.00, on Nov 3, 2025.
You can dive deeper into what analysts are projecting on the Apogee Therapeutics stock forecast page.
APGE Momentum
Who is buying/selling APGE?
In the past year, executives and large shareholders at APGE have sold more shares than they have bought.
Michael Thomas Henderson, Chief Executive Officer of APGE, was the latest APGE insider to sell. They sold $621,287.27 worth of APGE shares on Mar 11, 2026.
Dig into more about who owns APGE stock here.
Does APGE provide a stable income stream?
No, Apogee Therapeutics doesn't provide an income stream by paying out dividends.
What do other investors have to say about APGE?
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Make your APGE buy order
There are two main order types:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are usually sufficient. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at a particular dollar amount, place a limit order.
Hit the Open Trade button and your broker will place your order.
If you want more assistance investing in stocks on eToro, watch the helpful video below:
Step 6: Get key alerts regarding your APGE investment
Now that you own some shares in APGE, you'll want to stay up-to-date on your new investment.
Start a watchlist to get notified of important updates regarding your APGE stock.
APGE Feed
How to Buy Stock in Apogee Therapeutics
To summarize, here are the 6 steps to buy stock in Apogee Therapeutics:
- Choose where to buy Apogee Therapeutics stock
- Sign up for your brokerage account
- Deposit funds into your brokerage account
- Research Apogee Therapeutics stock
- Make your APGE buy order
- Get key alerts regarding your APGE investment
If you need a brokerage account, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get notifications regarding your investment in Apogee Therapeutics, click below.
Other Articles You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.